In Focus: Compliance and Start-ups

| 01 May 2010

Start-up companies and others in the early phases of drug, biologic and device development face a variety of issues and pitfalls. In addition to obtaining financing, these firms need an effective strategy and tactics to get from one milestone to the next. During this process, the company must, of course, follow the rules and regulations associated with bringing the product to market.


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy